SRx Health Solutions Acquires 4.99 Percent Equity Stake in Smartkem

SRx Health Solutions has acquired a 4.99% equity stake in Smartkem, Inc., a company currently traded on the NASDAQ under the ticker symbol SMTK. This transaction represents a strategic investment by SRx Health Solutions into the semiconductor technology firm, as confirmed by official filings released on June 8, 2026.

The acquisition grants SRx Health Solutions a minority interest in Smartkem, which specializes in the development of organic thin-film transistor technology for display and sensor applications. By securing this 4.99% position, SRx Health Solutions joins the list of shareholders invested in the company’s ongoing research and commercialization efforts. Smartkem continues to operate as a publicly traded entity, and this change in share distribution reflects the latest movement in the company’s ownership structure.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 8, 2026

Author

GOAI